Pimecrolimus
CAS 137071-32-0 6 FDA-DMF suppliersSmall Molecule
Overview
Pimecrolimus is an immunosuppressant used topically in the treatment of atopic dermatitis. It acts by inhibiting calcineurin, thereby reducing T-cell activation and the release of inflammatory cytokines.
Therapeutic areas
DermatologyImmunology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.